Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Endocrinol (Oxf) ; 70(2): 252-8, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18547339

ABSTRACT

OBJECTIVE: Pseudohypoaldosteronism type I (PHA1) is a rare inborn disease causing severe salt loss. Mutations in the three coding genes of the epithelial sodium channel (ENaC) are responsible for the systemic autosomal recessive form. So far, no phenotype has been reported in heterozygous carriers. PATIENTS: A consanguineous family from Somalia giving birth to a neonate suffering from PHA1 was studied including clinical and hormonal characteristics of the family, mutational analysis of the SCNN1A, SCNN1B, SCNN1G and CFTR genes and in vitro analysis of the functional consequences of a mutant ENaC channel. RESULTS: CFTR mutations have been excluded. SCNN1A gene analysis revealed a novel homozygous c.1684T > C mutation resulting in a S562P substitution in the alphaENaC protein of the patient. Functional analysis showed a significantly reduced S562P channel function compared to ENaC wild type. Protein synthesis and channel subunit assembly were not altered by the S562P mutation. Co-expression of mutant and wild-type channels revealed a dominant negative effect. In heterozygote carriers, sweat sodium and chloride concentrations were increased without additional hormonal or clinical phenotypes. CONCLUSION: Hence, the novel mutation S562P is causing systemic PHA1 in the homozygous state. A thorough clinical investigation of the heterozygote SCNN1A mutation carriers revealed increased sweat sodium and chloride levels consistent with a dominant effect of the mutant S562P allele. Whether this subclinical phenotype is of any consequence for the otherwise asymptomatic heterozygous carriers has to be elucidated.


Subject(s)
Epithelial Sodium Channels/genetics , Heterozygote , Mutation, Missense/genetics , Phenotype , Pseudohypoaldosteronism/genetics , Alleles , Chlorides/metabolism , Female , Humans , Infant, Newborn , Pedigree , Pseudohypoaldosteronism/metabolism , Sodium/metabolism , Sweat/metabolism
2.
Autophagy ; 2(2): 140-2, 2006.
Article in English | MEDLINE | ID: mdl-16874064

ABSTRACT

Despite abundant evidence for autophagic cell death as a morphological type, the notion that autophagy can actually contribute mechanistically to the cell's death is controversial. In cells capable of apoptosis, autophagic cell death has been dismissed by some authors as a morphologically unusual form of apoptosis. But strong recent evidence for autophagy-mediated death of cells rendered incapable of apoptosis has been criticized on the grounds that this cell death is too artificial to be relevant to normal cells. We here argue from our own and other recent evidence that autophagy can mediate the death even of apoptosis-competent cells.


Subject(s)
Apoptosis/physiology , Autophagy/physiology , Adenine/analogs & derivatives , Adenine/pharmacology , Androstadienes/pharmacology , Animals , Apoptosis/drug effects , Autophagy/drug effects , Chromones/pharmacology , HeLa Cells , Humans , Morpholines/pharmacology , PC12 Cells , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Rats , Signal Transduction , Wortmannin
SELECTION OF CITATIONS
SEARCH DETAIL
...